Literature DB >> 15599656

Analysis of quasispecies in the viral 5' untranslated region of hepatitis C virus to evaluate ribavirin mutagenic effect in patients receiving ribavirin and interferon-alfa.

A Vallejo1, S Molina-Pinelo, M A Abad, G Gómez, M Leal, A Sánchez-Quijano, E Lissen.   

Abstract

In the study presented here the ribavirin mutagenic effect was investigated by analyzing quasispecies in the viral 5' untranslated region of hepatitis C virus in six patients with chronic infection who started interpheron-alpha and ribavirin therapy. A remarkable mutation rate during treatment was found in only one individual. This patient had a sustained response and harbored a type 3a virus strain. The different mutated clones in this patient demonstrated no apparent close relationship that could suggest lack of selection pressure by ribavirin. The mutations were located within the loops of subdomains IIIb and IIId of the internal ribosomal entry site. This is an interesting initial finding that needs to be substantiated in a larger trial.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15599656     DOI: 10.1007/s10096-004-1238-x

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  13 in total

1.  Longitudinal evaluation of the structure of replicating and circulating hepatitis C virus quasispecies in nonprogressive chronic hepatitis C patients.

Authors:  B Cabot; M Martell; J I Esteban; M Piron; T Otero; R Esteban; J Guardia; J Gómez
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Early changes in hepatitis C viral quasispecies during interferon therapy predict the therapeutic outcome.

Authors:  Patrizia Farci; Rita Strazzera; Harvey J Alter; Stefania Farci; Daniela Degioannis; Alessandra Coiana; Giovanna Peddis; Francesco Usai; Giancarlo Serra; Luchino Chessa; Giacomo Diaz; Angelo Balestrieri; Robert H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-03-05       Impact factor: 11.205

3.  Dynamics of serum hepatitis C virus load and quasispecies complexity during antiviral therapy in patients with chronic hepatitis C.

Authors:  B Grahovac; J Bingulac-Popovic; B Vucelic; I Hrstic; R Ostojic; V Drazic; M Balija; D Grgicevic
Journal:  J Clin Virol       Date:  2001-01       Impact factor: 3.168

Review 4.  The molecular biology of hepatitis C virus. Genotypes and quasispecies.

Authors:  X Forns; J Bukh
Journal:  Clin Liver Dis       Date:  1999-11       Impact factor: 6.126

5.  Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity.

Authors:  S Sierra; M Dávila; P R Lowenstein; E Domingo
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

Review 6.  Hepatitis C viral quasispecies.

Authors:  J Gómez; M Martell; J Quer; B Cabot; J I Esteban
Journal:  J Viral Hepat       Date:  1999-01       Impact factor: 3.728

7.  Viral RNA mutations are region specific and increased by ribavirin in a full-length hepatitis C virus replication system.

Authors:  Ana Maria Contreras; Yoichi Hiasa; Wenping He; Adam Terella; Emmett V Schmidt; Raymond T Chung
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

8.  Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (IHIT)

Authors:  T Poynard; P Marcellin; S S Lee; C Niederau; G S Minuk; G Ideo; V Bain; J Heathcote; S Zeuzem; C Trepo; J Albrecht
Journal:  Lancet       Date:  1998-10-31       Impact factor: 79.321

9.  Quasispecies heterogeneity and constraints on the evolution of the 5' noncoding region of hepatitis C virus (HCV): relationship with HCV resistance to interferon-alpha therapy.

Authors:  Muriel Soler; Muriel Pellerin; Cécile E Malnou; Daniel Dhumeaux; Katherine M Kean; Jean-Michel Pawlotsky
Journal:  Virology       Date:  2002-06-20       Impact factor: 3.616

10.  Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group.

Authors:  J G McHutchison; S C Gordon; E R Schiff; M L Shiffman; W M Lee; V K Rustgi; Z D Goodman; M H Ling; S Cort; J K Albrecht
Journal:  N Engl J Med       Date:  1998-11-19       Impact factor: 91.245

View more
  1 in total

1.  Effect of ribavirin on the mutation rate and spectrum of hepatitis C virus in vivo.

Authors:  José M Cuevas; Fernando González-Candelas; Andrés Moya; Rafael Sanjuán
Journal:  J Virol       Date:  2009-03-25       Impact factor: 5.103

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.